Status:
COMPLETED
Traditional Chinese Medicine Formula Liu-Wei-Die-Huang-Wan in the Treatment of Osteoarthritis.
Lead Sponsor:
Chung Shan Medical University
Conditions:
Osteoarthritis
Eligibility:
All Genders
20-80 years
Phase:
PHASE2
Brief Summary
Through an eight-week randomized, double-blind, placebo-controlled clinical trials formula to evaluate Chinese herbal compound OA2 improve osteoarthritis of efficacy and safety.
Detailed Description
This trial was a 8 weeks' randomized, double-blind, placebo-controlled study. The study was approved by the Institutional Review Board of Chung Shan Medical University hospital, and signed informed co...
Eligibility Criteria
Inclusion
- Age ≥20 years old
- Written informed consent obtained
- Been diagnosed with knee or hip osteoarthritis
- The physician interpretation of X-ray identification and joint space narrowing or bone spurs confirmed
- In randomized trials before entering if used steroids or non-steroid medications osteoarthritis stable doses required at least one week
- The WOMAC osteoarthritis index of the degree of pain assessment in the past two weeks at least\> 4ppm pain
Exclusion
- Pregnant or breast-feeding women.
- Chemotherapy or radiation therapy in cancer patients
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT04108832
Start Date
January 1 2012
End Date
October 1 2013
Last Update
September 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung Shan Medical University Hospital
Taichung, Taiwan, 402